ERICSON DANIEL G has a total of 13 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are PEOPLES HOSPITAL XINJIANG UYGUR AUTONOMOUS REGION, SHANGHAI TENTH PEOPLE'S HOSPITAL and FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE ROSTOVSKIJ NAUCHNO ISSLEDOVATELSKIJ ONKOLOGICHES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Medical technology | |
#5 | Basic materials chemistry | |
#6 | Machines | |
#7 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Ericson Daniel G | 13 |
#2 | Sandhu Shivpal S | 1 |
#3 | Haworth William S | 1 |
#4 | Thor Eric J | 1 |
#5 | Thompson Jeffrey A | 1 |
Publication | Filing date | Title |
---|---|---|
US2011229871A1 | Nucleoside-containing compositions and methods for treating red blood cells | |
US2011256522A1 | Arginine-containing compositions and methods for treating red blood cells | |
US2009239248A1 | Rapid and sensitive detection of bacteria in blood products, urine, and other fluids | |
WO2007136781A2 | Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance | |
US2005255534A1 | Method and device for monitoring asprin response | |
AU2003267147A1 | Method and device for monitoring platelet function |